21 September 2021
The fast spread of the highly infectious Delta variant underscores the need for faster identification of COVID-19 mutations. Uniting governments and medical communities in this challenge, the University of Oxford and Oracle’s Global Pathogen Analysis System (GPAS) is now being used by organizations on nearly every continent. Institutions using the platform include: the University of Montreal Hospital Centre Research Centre, the Institute of Public Health Research of Chile, the Oxford University Clinical Research Unit in Vietnam, the Institute of Clinical Pathology and Medical Research – New South Wales Pathology, and Oxford Nanopore Technologies. GPAS is also now part of the Public Health England New Variant Assessment Platform.
20 September 2021
‘Finding Our Way – An NHS Tribute Garden’ is a celebration of the incredible efforts of the thousands of people who fought – and are still fighting - the COVID-19 pandemic on our behalf. Designed by Naomi Ferrett-Cohen and presented by Oxford University Hospitals NHS Foundation Trust and Oxford University.
31 August 2021
Writing in the journal Nature Immunology, they detail an investigation into one of the key features of adenovirus vaccines – their ability to generate strong and sustained populations of the ‘killer’ T-cell element of the immune system.
31 August 2021
The University has signed an agreement with Sensyne Health to conduct a multi-omics drug discovery research project in asthma. The project will be led by Dr Timothy Hinks at his team at the Nuffield Department of Medicine’s Respiratory Medicine Unit.
20 October 2020
Two vital research programmes taking place at the University of Oxford may hold the key to understanding the immunity of recovered Covid-19 patients. The data will also be used by Professor Sarah Walker at the University of Oxford who is working with the Office for National Statistics on the COVID-19 Infection Survey.
12 October 2020
Prof Walker, Professor of Medical Statistics and Epidemiology at the University of Oxford’s Nuffield Department of Medicine, was recognised for services to academia and the COVID-19 response and will receive an OBE.
25 September 2020
Scientists from the University of Oxford’s Nuffield Department of Medicine have today published their evaluation of LamPORE, a novel diagnostic platform for detecting SARS-CoV-2 RNA. It combines loop-mediated isothermal amplification with nanopore sequencing. This technology has the potential to analyse thousands of samples per day on a single instrument.
3 February 2020
Many congratulations to Prof Anne Goriely and Prof Alison Simmons, who have both been awarded Wellcome Trust Investigator Awards.
13 August 2019
The Medical Sciences Divisional Panel has conferred the title of Professor on six members of NDM's academic staff.
15 July 2019
Johnson & Johnson Innovation - JLABS announced on 11th July that the Translational Gastroenterology Unit, University of Oxford, has been selected as the awardee in the IBD Stress Test QuickFire Challenge.
8 May 2019
Eight Oxford scientists are amongst 50 of the UK's world-leading researchers elected to join the prestigious Fellowship of the Academy of Medical Sciences this year.
7 December 2018
Viral hepatitis is on the rise. Tackling hepatitis B in Africa is key to fighting back. “HIV has been an acute pandemic with resources thrown at it.
31 July 2018
For services to Clinical Medicine, Peter Radcliffe, Head of the Nuffield Department of Clinical Medicine, and Fellow of Magdalen College recieved a Knighthood in the New Year Honours.
21 June 2018
An analysis of antibiotic use at the John Radcliffe hospital has shown that some Doctors use up to 30% less antibiotics without risk to patients. However they may admit more patients when the diagnosis is unclear - a ‘hold and observe’ strategy as opposed to ‘prescribe antibiotics and discharge’.
18 April 2018
Following a successful clinical trial, Dr Alissa Walsh, the main researcher, who works with Professor Simon Travis, has spoken about the online tool that allows people with a form of inflammatory bowel disease (IBD) to manage their own condition and reduce hospital visits. This is now being rolled out to more patients in Oxford who suffer from ulcerative colitis.
3 May 2017
Asthma is a chronic disease of the airways that is on the increase. 5.4 million people receive asthma medications in the UK each year. That is 1:12 adults and 1:11 children. Asthma is treatable and it is frustrating that despite the amount of treatment prescribed, one patient with asthma has an attack every ten seconds, and approximately 17% of asthma patients find it a disease difficult to.
5 April 2017
Oxford Researchers have identified a potential therapeutic target for inflammatory bowel diseases. The findings are of particular importance to the 40% of patients who don’t respond to anti-TNF therapy, the current treatment option available. Professor Simon Travis co-led this study.
2 March 2017
Although viral sequences are important in traditional taxonomy, information used for virus classification typically requires information on their biological properties, such as host range, pathogenicity and virion structure as well as genetic relationships. In his recent Consensus statement, Professor Peter Simmonds proposes sequence-only classification, enabling much of the viral diversity observed in metagenomic sequence datasets to be incorporated into official virus taxonomy.
4 November 2016
The NDM Graduate Prize winners for 2016 are Emma Davenport, Symon Kariuki, Sarah McCuaig, Manuel Rivas and Joshua Tan. The winners were awarded a £500 prize. This year’s winners have worked across many research areas including malaria vaccine work, behavioural studies and software development.
13 September 2016
Professor Sir Peter Ratcliffe has won one of the most prestigious prizes in medicine. The Lasker Awards recognise contributions that have allowed major advances in the understanding, diagnosis, treatment, and prevention of human disease. Professor Ratcliffe is to receive the prizes for his work understanding the mechanisms by which cells sense and signal hypoxia (low oxygen levels), an important component of many human diseases including cancer, heart disease, stroke, vascular disease, and anaemia.